What is the new change in RNTCP
High-Yield Explanation
New strategies in Treatment of TB (RNTCP) Dailu regimen for treatment of TV (to Gradually replace Thrice weekly Intermittent regimen) Use of Bedaquilline for treatment of drug resistant TB with drug susceptibility testing (DST) guided treatment Information communication technologies (ICT) - based adherence suppo Post-treatment follow up Treatment protocol : New guidelines Patients are given fixed drug combinations (FDCs), on a Daily basis (1 November 2017 onwards PAN-India) Reduced pull burden : 3-4 drugs in a single pill(as against 7 tablets earlier) Lesser relapse Reduction in drug resistance Greater compliance Pediatric patients are given easily-dissolvable and flavoured drugs (instead of bitter tablets earlier) Weight bands: Patients get appropriate dosages as per body weight TB-HIV Co-infection 'Intensified TB case finding and appropriate treatment' through single window delivery of services from all A centres INH preventive therapy for prevention of TB among PLHIV Implementation of pharmacovigilance by establishing adverse drug reaction monitoring centres at A centres Patients not registered under DOTS are provided with intermittent (alternate day or thrice weekly) regimen Ref: Park 25th edition Pgno : 195